Abstract
Objective: Laryngeal papillomatosis is a rare disease, benign, recurrent, with potential for malignancy according to viral type and aggravating factors. Its high recurrence raises different therapeutic modalities. Here we review our experience in 20 years on behavior and type of performed treatment.
Method: A descriptive study of a cohort of patients of the University Complex Hospital to Vigo (CHUVI) from January 1990 to December 2010 with papilloma and recurrent respiratory papillomatosis.
Results: We found 37 cases, 4.35 incidence rate per million population per year, average age 49 years, 81.1% males, 71% history of smoking, 51.4% had symptoms years before the first consultation, 33.3% settled on right vocal cord, 64.9% treated with CO2 laser, 51.5% histology compatible with human papilloma virus, 6 cases became viral typing, 4 positive and 100% HPV type 11. A total of 47.2% relapsed, the average number of interventions was 5 times per patient, 18.9% malignant and none of them had HPV study, 13.8% laryngectomy was performed, until the time of study 43.3% cured and 10% in remission.
Conclusion: In our area, laryngeal papillomatosis is a rare disease, more common in middle-aged men with malignant potential and frequent relapses. It is important to study HPV monitored closely and cessation of toxic habits after surgery. It is necessary to seek alternative therapies.
Get full access to this article
View all access options for this article.